Alzamend Neuro, Inc. ALZN
1.40 USD -0.15 (-9.68%)
Nov 6, 2026, 2:51 PM EST
1.34 Day range 1.66
0.84 52-week range 2.56
- YTD
- -23.08%
- 1 year
- -44.44%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 32.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29 | -0.29 – -0.29 | -3.80 | +92.4% | 0 | 0.0% | 1 |
| Next quarter | -0.45 | -0.45 – -0.45 | -13.35 | +96.6% | 0 | 0.0% | 1 |
| Current year | -1.68 | -1.68 – -1.68 | -14.70 | +88.6% | 0 | 0.0% | 1 |
| Next year | -1.71 | -1.71 – -1.71 | -1.68 | -1.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Nov 11, 2024 | Ascendiant Capital | Maintained | Buy | Buy |